Pfizer Inc. (NYSE:PFE)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for PFE
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- DavidK: $PFE- my calls getting wacked . Thanks Josh Brown for steering me to this pos . Anyone have opinions on this chart . I had mine and so far wrong . I am like the fox who broke off the love affair with the skunk 🦨, he had not had all he wanted just all he could stand .
- woodman: $VKTX broke out last week, then sideways last few days. Now making a little flag. It is extended from the 50d and 200d with the 50 going to cross above the 200d soon. Shorter term, the 8dEMA has caught up again. It has oral and subq obesity drug cand ...
- bigbartabs: @DavidK $PFE ... I would sell and wait for it to recover the 20dma, and the 8dema.
- joelsg1: @woodman $VKTX $LLY $AMGN $PFE You are kinda the expert around here :)
- joelsg1: @DavidK $PFE Don't buy anything pitched on tv, at least not immediately. There is always a reason why the producers decide to show it to you. Doesn't make them crooks, just reality. On chart, the adage applies: 'Nothing good happens under the 200d'.
- phgruver: @DavidK $PFE As a short term trade or swing trade, I think there are better candidates. As a long term, income producing hold, $PFE still looks pretty good. The yield is up to 5.85%. The recent low was $25.76, but you don't want to give it that much space. As long as it holds above $28, I think you can own it.
- woodman: @joelsg1 $VKTX $LLY $AMGN $PFE https://i.gifer.com/1VF5.gif
- DavidK: @bigbartabs $PFE just sold before I saw your post . Thanks bought more $ TLRY. These pot stocks ($TLRY actually has lots of alcohol brands ) are spring loaded . There seems to be some encouraging developments regarding govt release of some studies . I like Tilray ceo as well . Good track record
- DavidK: @phgruver $PFE I had March calls that’s why I didn’t want to hold much longer . I usually don’t buy based on Tv touts but when I looked at the chart I thought it might be a candidate for a bounce and I quick trade.
- joelsg1: @woodman $VKTX $LLY $AMGN $PFE More hair than I'd imagine.
- woodman: @joelsg1 $VKTX $LLY $AMGN $PFE - Am I not using my nose-hair scissors (that I told @bigbartabs about) enough?
- phgruver: I'm not seeing much to do, today, but one thing of note: If $PFE holds yesterday's low of $28.27, this may be a good place to add in a LT account. $BMY also looks good right here for an income producing portfolio. Both of these are lagging their peers $ABBV, $GSK, $LLY & $MRK, so I expect them to play catch up.
- DavidK: $PFE- well it’s down $1 since Josh Brown recommended it a few days ago . I have March 29 calls . Might add around this level . On anther note , no way Fed drops rates anytime soon unless it’s in the Tank for Biden trying to juice markets even more . They didn’t work this hard trying to tame inflation to just drop rates .
- DavidK: $PFE - Josh Brown buying based on change in technicals . He went Thru a lot of reasons . I bought some March Calls . I don’t like the company and CEO at all but might be some Money to be made short term .
- Margi1983: @woodman $CLRB Thanks for the update. Long with modest position. You really know your biotech stuff. These others are not really biotech but I am also long $VRTX, $LLY, $NVO, and $PFE in the pharma space
- woodman: @Margi1983 $CLRB $VRTX $LLY $NVO $PFE - I won't hold all my shares through, but I still need to decide how much I will hold through. It's risky for sure. I can't imagine the company would be promoting this data so much into the presentation(s), but crazy stuff happens in BioLand. It could be a disappointment even if "good" or just simply an immediate sell the news. One never knows.
- camaro69: @phgruver $PFE $XLV Thanks for your post! This has been an easy one to hold since you posted
- Onthemark: $PFE breaking above 50d, would wait for pullback. Don't trust breakouts, better to buy bounces.
- Wolf: @Onthemark $PFE $ABBV is breaking out as well. Tagged the upper BB on decent volume. No position.
- Margi1983: $PFE reached a 10 year weekly low of $25.76 on 12/12/23. For my #LTInvestment account, I went long that day at 26.32. Now moving above the 50 ma today which is 29.47. Has 5.8% divi. This is LT value play. Revenue guidance for 2024 is quite flat, but EPS are expected to increase by 24% ( EPS from 1.45 -1.65 in 23 to 2.05-2.25 in 2024). $PFE needs to hold the 50 ma. Guidance for 2024 link here https://www.pfizer.com/news/press-release/press-release-detail/pfizer-provides-full-year-2024-guidance
- DavidK: @Margi1983 $PFE #LTInvestment well it is an election year and another pandemic could be brewing up just in time for another mandated school closings , business shutdowns , vote from home and another vaccine from Pfizer that doesn’t work as advertised .
- woodman: @DavidK $PFE #LTInvestment - It "advertised" that it would help people stay out of the hospital and stay off a ventilator or die. It never "advertised" that it would make one immune and not catch covid-19. It has worked as "advertised." I was vaxed multiple times. I've caught covid twice. I hardly had any noticeable symptoms. I know folks who weren't vaxed and became very sick. Anedotal, in my case, but true to the "advertising."
- woodman: $PFE #LTInvestment And I know someone who was reasonably healthy, as far as I know, but he refused to get vaccinated. He caught covid-19 and died and left a family behind. Very sad.
- DavidK: @woodman $PFE #LTInvestment -per Joe Biden ( check the documented video and others on his staff) if you got the vax , you wouldn’t catch Covid . Bs I got 2 shots , caught it , got an infusion because I have had afib for years ( but had an ablation in March 2020 with ZERO afib flare ups ) until the infusion about killed me . Knocked my heart out of rhythm so badly I thought I was having a heart attack ). Many many many DRs I know including my father in law DR said no more . They knew the vac had heart related issues but pushed it anyway . It would have never ever passed FDA approval in its original form
- champ: @woodman $PFE #LTInvestment....I know couple of guys in their 80's, that aren't healthy, they smoked and drink and both that caught Covid twice and both were down for 2-weeks, with what they said was the worst flue that they ever had....and both were back playing golf after 3-weeks...... ....and I know many others that are in their 70's that also caught Covid...... and all had 3-shots. Many active golfers caught COVID, at my golf course, even the club mangers and all are doing find and one guy was 92 and another one was 95 and both are still shooting under their ages. It all depends on each person on how they do.
- DavidK: @champ $PFE #LTInvestment My Dr father in law just caught it and he is 91 and is he is doing fine so far .On Golf , I shot my age this past summer at Madison Country club in Ohio . 67. We have a summer home on Lake Erie and go up in summer . Brother there now last month snow hunting !
- champ: @DavidK $PFE #LTInvestment...#Nice-round, you must be a natural, I started playing golf are 52 and my best rounds ever were all at 72, could never get below that number because my head would always get in the way.
- wijimmy: @DavidK, @champ, @woodman, @margi1983, ...$PFE... To many Lawsuits in the works and coming soon...here are just 2 examples .. . George Watts died on October 27th, 2021 after collapsing in his room. An autopsy report from the Bradford County Coroner’s Office says he died from “COVID-19 vaccine-related myocarditis” which is an inflammation of the heart... . https://www.mytwintiers.com/news-cat/covid-19-vaccine-killed-our-son-says-lawsuit-against-dept-of-defense/ .. Texas Attorney General Paxton. “The facts are clear. Pfizer did not tell the truth about their COVID-19 vaccines. Whereas the Biden Administration weaponized the pandemic to force illegal public health decrees on the public and enrich pharmaceutical companies .. . .https://www.texastribune.org/2023/11/30/texas-attorney-general-pfizer-lawsuit/ . .https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-sues-pfizer-misrepresenting-covid-19-vaccine-efficacy-and-conspiring . .https://www.reuters.com/legal/pfizer-is-sued-by-texas-over-covid-19-vaccine-claims-2023-11-30/
- DavidK: @champ $PFE #LTInvestment #Nice-round played high school / jr college then at GA started Partying , no golf . Don’t play much 3 times a month . Gonna get back at it this spring . I did win club championship at 3 different clubs over the years though . Last 2 rounds 73-79
- phgruver: @DavidK $PFE #LTInvestment #Nice-round I did tell people to buy $PFE when it was below $28! Just sayin.....
- woodman: @wijimmy $PFE https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537923/#:~:text=They%20determined%20the%20number%20of,COVID%E2%80%9019%20in%20a%20year. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00320-6/fulltext https://www.cdc.gov/respiratory-viruses/whats-new/5-things-you-should-know.html https://www.cidrap.umn.edu/covid-19/report-covid-19-vaccines-saved-us-115-trillion-3-million-lives And on and on.
- Margi1983: @phgruver $PFE #LTInvestment #Nice-round Thanks phgruver. Let's keep this Forum focused on stocks not vaccine politics. My post at 2:10 PM today had nothing political, nothing about Covid, only the link to $PFE's 2024 guidance
- phgruver: @Margi1983 $PFE #LTInvestment #Nice-round ... I think you must have misread my post....
- phgruver: If anyone is interested, $PFE has filled the gap from 12/12/23, and is now trading above the closing price of the day before the gap down. These "bad news" selloffs are often buying opportunities. Almost all the members of the health care sector ($XLV) are trading near 52 week lows. For a long term, income oriented portfolio, this is something to consider, going into the new year.....
- DrScience: @phgruver $PFE Bad news selloffs *are* buying opportunities... Right up until they're not! Now, we need the stock to hold the 21 EMA and for the 8 EMA to cross from below as a signal that buyers continue to like the stock.
- phgruver: For anybody who might be considering income, $PFE was a buy on this pullback. I couldn't buy it on 12/13 or 12/14, because I didn't know where support was. Now, however, we know that support is $25.76, and that institutions are stepping in to pick up 6% income. There is still time to add this to your long term income portfolio, (unless you really believe that big pharma are a bunch of crooks who are out to make us all sick, and kill us with their drugs) as $PFE is bouncing along a multi-year lows. This company is not going out of business, just saying....
- Margi1983: @phgruver $PFE I agree. Good one for LT investment. I went long at $26.32 and intend to stay long.
- Motorman: @joelsg1 $GPCR $LLY Jeffries analyst said best in class should exceed 7%. But at least not pulled like $PFE candidate. Added at 28 to a small position.
- woodman: @Motorman $GPCR $LLY $PFE - $PFE needs an obesity asset. It will acquire someone, I speculate.
- Wolf: $PFE tried to fill the gap down, but got rejected.
- Wolf: $PFE Lowered #Guidance this AM. Down 6% PM. Down over 50% from 52 Wk high. 5.74% Div at this price if they don't cut it.
- phgruver: @Wolf $PFE #Guidance EPS in 2023 was $1.82, and they are projecting $2.05 to $2.25 for 2024. They also lowered guidance for revenues to $58.5B to $61.5B for 2024. That would seem to support the current dividend, without a problem. This may be a buying opportunity, but I wouldn't get in a hurry. Let's see how this settles out.
- traderbren: @Wolf $PFE #Guidance - yep, as I posted a few weeks back, it never ceases to amaze me how many so called "professional" penguins have come out pushing that $PFE is a buy over the last 2 months. They obviously don't know what a ski slope looks like. ;-) Maybe today is the turning point but I won't be the first guy out of the fox hole.
- phgruver: Possible bounce play with $PFE. The dividend is $0.41/qtr, which equates to 5.67% at this price. Unless you expect $PFE to totally collapse, this is a pretty good #VALUE entry for a solid income in a long term portfolio. $XLV, in general, is down near lows, although $LLY and $NOV seems to be bucking that trend. (I also own $ABBV and $BMY for income)
- traderbren: $PFE - not surprising how many Talking Heads on the Box have recommended $PFE all the way down...and it keeps heading south. Obviously, they don't know how to look at a chart!?! ;-)
- traderbren: @woodman $LLY - yep, I'm still long too. The news of the $PFE tab sounds like a good alternative to lose weight with side effects of puking & diarrhea! Yikes. ;-)
- woodman: $PFE relentlessly downward essentially since hitting its ath of $61 and change in Dec. 2021. It has pulled back to its 200 month ma, not that that's demonstrating any particular significance thus far. More interesting to me as a potential bounce area would be a re-visiting of its multi-bottom area of 26-27. But for now it continues to fall. No position.
- woodman: @Momentariness $MRNA - And $PFE, and $BNTX which moved even more. I caught none of them.
-
DAN: ...
[Note: You might also want to watch the COVID vax stocks. Apparently annual boosters are definitely a thing. The government is pumping them along with the annual flu shot, and I’m sure that there will be pervasive compliance by those who are ... - woodman: $ORIC - Moving well out of consolidation, up through $9 resistance. Lots going on with ORIC. I think its moving today on Baird's increased PT from $15 to $27, which is probably based on news regarding $PFE (a collaborator with ORIC). Recall that $PF ...
- jwstich: @woodman $ORIC $PFE $JNJ Thank you for your well done update. Been adding to this poition over the last few months. I really appreciate what you add to the forum and always raed your posts.
- woodman: @jwstich $ORIC $PFE $JNJ - Thank you. Much appreciated.
- bud_ozborn: I am seeing movement out of tech names and into pharma and banks RED $DDOG $SPLK $ARKK $CRWD green $ABT $LLY $BMY $MRK $PFE $KEY $PACW $SCHW $GS $STNE $NU
- vitoB: Took a look at diagnostic companies per a post on $MTD. But $DHR $TMO $A all have similar charts and might be a good candidate for sector rotation. Also in a similar light, cant believe that $PFE chart.
- woodman: @pperlroth $EFTR - Thanks for additional information. Two of their three programs/targets ((a) non-small cell lung cancer; (b) solid tumors/breast cancer/NSCLC) are in Phase 2 with topline data coming for (a) [Phase 2b] and dose escalation data for (b) [Phase 2a] this half of the year. Their third one also for solid tumors - on which they are working with Pfizer - is still in the pre-clinical stage. https://www.pfizer.com/news/press-release/press-release-detail/effector-enters-agreement-pfizer-inc-develop-novel-first- See also: https://effector.com/pipeline/ The CEO has good experience with some notable successes. He was involved with the acquisition of his previous venture, Anadys, by Roche for $230 million. He also was involved in the successful commercialization of HIV protease inhibitor that later acquired by $PFE.
- woodman: @joelsg1 $VKTX $ALT - I'm with you. I have only a small reminder position in VKTX as well. It's all about $LLY's obesity drug. Even $PFE out of favor now that it ditched one of its treatments in favor of a two a day pill, but is far behind on a one a ...
- woodman: $ORIC holding up well with a doji today after yesterday's strong move. I'm still in this. Remember that $PFE is partnered with ORIC (in ORIC-533 - which has data coming in 2H this year - anti-tumor activity from ongoing single agent Ph1b study in patients with multiple myeloma) and bought a bunch of ORIC stock at $4.65/share in December. PFE saw early data in the trial they partnered with. Its CSO for oncology and R&D joined $ORIC scientific advisory board. It knew what it was buying. There also was a private placement for big healthcare funds at a premium; participating investors entered into confidentiality agreements and executed lock-up agreements with ORIC to restrict their ability to sell ORIC shares. Lots of confidence here from big money. Riding the coattails.
- joelsg1: @woodman $VKTX $ALT $LLY $PFE $TERN Following your lead on these, but obvious concern that the Big Boys' oral formulations will swamp little guys like $VKTX. Also concerned about the thyroid cancer risks being studied, where hopefully $VKTX may have better profile.
- woodman: @joelsg1 $VKTX $ALT $LLY $PFE $TERN - Very valid concerns. And the small guys are years away. Perhaps a PFE type scoops one of them up in time. Not holding my breath. The need more data.
- woodman: @joelsg1 $VKTX $ALT $LLY $PFE $TERN - VKTX looks destined for the 11s-12s.
- phgruver: @woodman $VKTX $ALT $LLY $PFE $TERN $PFE has been in a downtrend for over a year, peaking in Dec 2021. Part of this mimics the market, but the past 6 months, $PFE has definitely under performed. At the current price, the $.41/qtr dividend produces a 4.45% return, something to consider for income in a LT account. As one of the big dogs in that space, I would consider adding, cautiously, to $PFE as a #VALUE play.
- woodman: Crazy day for bios today, and mostly not in a good way. I've sold a bunch of $VKTX as it has fallen through multiple levels of support. I'll revisit it after some dust settles. There are a lot cross currents in obesity (following the American Diabete ...
- sierramp: @woodman $VKTX $LLY $NVO $PFE $TERN $XFOR As always, thanks for your informative, well thought post. Appreciate it.
- BarryC: HI Everyone, Hope ya have a good evening! I put on a few new trades yesterday, things that were on my watchlist AND bought some $RIOT with you guys, thanks to @scotttrades pointing it out. I went home #long: $FISV, $GOOG, $LRCX, $LTH, $MARA, $RIOT & $SHOP ALSO have some speculative smaller positions in $HBIO, $IMGN, & $NNOX. #btw, I got shaken out of $NOV on that $PFE news. I will still watch closely, in fact MANY of my good ones I wind up trying 2/3X sometimes before they work.
- Docoof: $PFE HOD
- Docoof: #CNBC reporting the following as breaking #news: $PFE Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says. * An oral drug from Pfizer causes a similar amount of weight loss as the blockbuster Ozempic injection, made by rival Novo Nordisk, according to results from a phase two clinical trial. * The results were presented at a medical conference late last year but JAMA Network now has released the full peer-reviewed study. * New York-based Pfizer’s pill could also offer an advantage as an oral treatment option rather than a frequent injection.
- Onthemark: @Docoof $PFE #CNBC #news Interesting here. Highest buying volume in quite some time.
- joelsg1: @Docoof $PFE #CNBC #news Like the pill formulation as people hate needles, that's why I'm in $VKTX, but need comparison with LLY's drug.
- Docoof: $PFE HOD
- debeers: $DKNG/$$EXAS/$GOOGL/$META/$PFE/$PR-my acquisition candidate stock in the oil space/ $TSLA-
- scottrades: Some earnings to be aware of next week: $AAPL $SOFI $AMD $NCLH $UBER $SHOP $PFE $F $ON $AMC $SQ $CVS $YUM $ANET $QCOM $COIN $DKNG $ALB $CHKP $BP $BUD $DDOG $MRNA $ET $RCL $SEDG $ACMR $SMCI $MELI $GPN $SBUX $CNA $MGM $MAR $WBD $RIG $PK $MPC $FANG $EPD $NVO $PTON $STNG $FUBO $LNG $AMG $CAR $WEC $LYFT $LUMN
- woodman: $ORIC, which has a nice run since March is pulling back and now testing rising support (from last Nov.) and the 50d (and occuring at the bottom BB). Technically, the recent lower high (4/17 vs 1/23) is somewhat of a concern, but can also be viewed as ...
- steve71: @woodman $ORIC $PFE Great summary. That PFE buy gives me a lot of confidence in Oric's prospects. Patience here will probably be rewarded. My position is about 5% filled and just slowly adding on pullbacks. Like today!
- woodman: @steve71 $ORIC $PFE - Thanks. Makes sense. My position is more advanced, which may or may not be a good thing.... :-?
- Bs7518: @woodman $ORIC $PFE Thanks for the update is this add territory ?
- phgruver: Healthcare, $XLV, is holding support and showing promise. All my healthcare stocks, $ABBV, $BMY, $CVS, $PFE are looking good right here.
- phgruver: I like the way $XLV is setting up on the daily chart. It's above the 200dma, holding support at the 50dma and trading just above the lower Bolenger Band. To me, it looks poised to move higher over the next couple of weeks. $XLV has nearly 20% of it's assets in $UNH and $JNJ, and another 5% in each of $LLY, $ABBV, $PFE and $ABT. Not surprisingly, all those underlying stocks have charts that look pretty similar. I own several stock in this space, (which I don't trade) and use options on $XLV to add to my returns. Many of these stock are good dividend payers, which pay well in the long term, if you get good entries.
- Docoof: @woodman @joelsg1 @issues @bigbartabs @bb_b $TSLA $TSLS You’re the cool kids, so I want to have a post in this thread. $AAPD = $AAPL Bear 1X $AMZD = $AMZN Bear 1X $GGLS = $GOOGL Bear 1X $MSFD = $MSFT Bear 1X $NVDS = $NVDA Bear 1.25X $PYPS = $PYPL Bear 1.5X $NKEQ = $NKE Bear 2X $PFES = $PFE Bear 2X #Crypto #Bitcoin $CONL = $COIN Long/Bull 1.5x
- phgruver: @vcondry $LLY Healthcare, $XLV, in general is getting hammered. $BMY is my biggest looser, today, but $ABBV, $CVS, and $PFE are all down biggly. I can't find any news either, but there was a big run up going into the election, so maybe just a bit of profit taking, although down 4% to 5% seems a bit extreme for basic profit taking.....
- vcondry: @phgruver $LLY $XLV $BMY $ABBV $CVS $PFE did find a report that early this morning some fake verified Twitter accounts including one for Lilly that was not legit said "Insulin is now Free" which got spread everywhere causing a big hit but other then that yes it seems pretty excessive for $JNJ $LLY etc Like I said its been a pretty decent buying opportunity before but who knows.
- phgruver: Big Pharma's $PFE reported Q3 earnings this morning, before the bell. They reported an adjusted EPS of $1.78/share, up 40% YoY, and above consensus expectations of $1.39/share. Revenue was down slightly, YoY at $22.64B, but well ahead of consensus expectations of $21.7B. Guidance for 2023 was revised upward within the range previously given, and doesn't seem to be having any negative affect on the stock price. (numbers vary slightly from source to source). Whereas $PFE is trading near the low end of their 12 month range, this report seems to being taken as a positive, and shares are up about 2.45% at this time.
-
DAN: ...
$PFE -- Down 30%.
- phgruver: @traderbren $LLY Right now, in health care/pharma, ($XLV) I'm holding $ABBV, $BMY, $CVS and $PFE. All are doing OK, but I couldn't recommend buying or adding RHRN. Everything seems to be under pressure. Time to go do something else. It's a waste of time to sit here watching the market flounder.
- champ: @DAN $DLTR $SPY $DIA $IYT $MDY $IWM $QQQ $FFTY $DQ $CF $OXY $SSO $QLD $NOG $DRVN $RTX $CLR $SLB $MRO $NVDA $OBE $APA $HAL $PFE $MRNA $AZN $PTON........Yes sir, you said that correctly and that is exactly what I'm always thinking.........."by the Time we see it on the chart, it's #Old News"........... .......working #Pre set-ups is always important........ Monday will be a very important Day for the Markets and actually for all of next week, could either be more Sellers or Buyers, buying the dip, however the odds are, or the guess is, the Markets will probably drop lower, for a few more days and stock Pickers will also be at Work......Good Luck to All.....
-
DAN: ...
$PFE on any bounce. 200-day MA is now pointed lower. Nobody’s buying this.
$MRNA -- on any rebound. This stock failed at the 200-day MA, and now at the 50-day MA. The rats have been fleeing the sinking ship for a while.
$AZN -- Potentia ... - jonwest88: @DAN $DLTR $SPY $DIA $IYT $MDY $IWM $QQQ $FFTY $DQ $CF $OXY $SSO $QLD $NOG $DRVN $RTX $CLR $SLB $MRO $NVDA $OBE $APA $HAL $PFE $MRNA $AZN $PTON When were the stop on $QLD changed as you show above? When was $DRVN changed to sell to close above $32? Cannot find them anywhere except here late in the day
- vcondry: @jonwest88 $DLTR $SPY $DIA $IYT $MDY $IWM $QQQ $FFTY $DQ $CF $OXY $SSO $QLD $NOG $DRVN $RTX $CLR $SLB $MRO $NVDA $OBE $APA $HAL $PFE $MRNA $AZN $PTON Morning market update at 9:18 am via email EDIT : was emailed but he forgot to post in the forum. when it rains it pours...hope your day is less worse than mine :-)
- jonwest88: @vcondry $DLTR $SPY $DIA $IYT $MDY $IWM $QQQ $FFTY $DQ $CF $OXY $SSO $QLD $NOG $DRVN $RTX $CLR $SLB $MRO $NVDA $OBE $APA $HAL $PFE $MRNA $AZN $PTON Yeah I searched for them here. Silly me. Did not get update until later.
- DAN: @jonwest88 $DLTR $SPY $DIA $IYT $MDY $IWM $QQQ $FFTY $DQ $CF $OXY $SSO $QLD $NOG $DRVN $RTX $CLR $SLB $MRO $NVDA $OBE $APA $HAL $PFE $MRNA $AZN $PTON Did you watch all of my videos?
-
DAN: @jonwest88 $DLTR $SPY $DIA $IYT $MDY $IWM $QQQ $FFTY $DQ $CF $OXY $SSO $QLD $NOG $DRVN $RTX $CLR $SLB $MRO $NVDA $OBE $APA $HAL $PFE $MRNA $AZN $PTON
Here is the email that I sent out this morning:
Morning Market Update
Good morning. Futures are p ... - champ: This is Setting-up, for tomorrow, is my guess...$MRNA...now at $143.00, LOD was at $13921 and this stock will be on all the evening News channel, this will be all about their New booster shot....and this New shot will be the New normal, like the yearly Flu shots.....plus this stock can move much better than $PFE. .....This stock now has a new positive reason to move back up to their August high, which was at $197.44, after their last earnings report.....because their New Booster shot, will increase their next earnings report also, for sure.
- natural: @champ $MRNA $PFE Big volume on $MRNA in the last 15 mins. Good thought, I think.
- vcondry: @champ $MRNA $PFE added it to my watch list, thanks!
- traderdl: $PFE in talks to buy $GBT - $XBI $LABU hod
- scottrades: My notes: $SPY / $QQQ Awaiting the Fed $UUP The Wrecking Ball $TNX Holding support $TLT Watching $GLD Watch tomorrow $SMH Needs to hold above the 50 Day $XHB Needs a base $URA Small here $TAN Lots of Earnings this week $ARKK Needs a base $AAPL Earnings This week $MSFT Earnings tonight $GOOGL 69.69B $AMZN Earnings This week $CEIX Back in Black $ARLP New High but extended now. $FLNG Working but extended $ATGE Low Volume but in an uptrend. $VRTX Mentioned in the forum $PFE Earnings coming up. $HSY Earnings coming up $LLY In an uptrend. Earnings Next week $CI Same $TWTR Flag, but under the 200 Day $MCD Big Mac Attack
- AboveWater: @scottrades $SPY $QQQ $UUP $TNX $TLT $GLD $SMH $XHB $URA $TAN $ARKK $AAPL $MSFT $GOOGL $AMZN $CEIX $ARLP $FLNG $ATGE $VRTX $PFE $HSY $LLY $CI $TWTR $MCD Thank you Scott - great to have you back in the Forum!
- Docoof: #SingleStockETFs The SEC approved 8 single-stock ETFs last week that are now trading: $TSLA Bear Daily ETF ($TSLQ) 1.25X $NVDA Bear Daily ETF ($NVDS) 1.5X $PYPL Bull Daily ETF ($PYPT) and 1.5X $PYPL Bear Daily ETF ($PYPS) 2X $NKE Bull Daily ETF ($NKEL) and 2X $NKE Bear Daily ETF ($NKEQ) 2X $PFE Bull Daily ETF ($PFEL) and 2X $PFE Bear Daily ETF ($PFES) https://www.prnewswire.com/news-releases/axs-investments-launches-first-ever-us-suite-of-single-stock-leveraged-bull-and-bear-etfs-301586789.html https://www.investopedia.com/first-leveraged-single-stock-etfs-launch-5649193
- woodman: This is a list of #Gene editing/therapy #Car-T stocks (#Biotech subset). I haven't updated it in some time, so it's not an up-to-date/complete list, but it provides a number stocks that are acting very well and, if you've paid any attention to this area over the years, you'll certainly recognize many of them (including $NTLA which @Dan added to his list today). If interested, kick some of their tires over the weekend (listed below in order of performance today). $ABEO $ADVM $EIGR $PGEN $QURE $RARE $AGTC $SRNE $BLUE $PRTA $CLLS $AVRO $MGTX $ADAP $KRYS $SRPT $BMRN $AMGN $ARCT $RGNX $CNCR $SLDB $TCRT $AGIO $NVS $JNJ $PFE $IOVA $NTLA $SGMO $LUMO $EDIT $VYGR $ORTX $CRSP $BLCM $BBIO
- Kid2old: @Mikev200 $ABBV Also have a small position in $ABBV. Watching $LLY $JNJ $MRK $PFE.
- joelsg1: $PFE Out for essentially divi plus lunch. Worst in class.
| Stock Price | $25.43 |
| Change | 0.04% |
| Volume | 3,436,710 |
Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare.
Request Video of PFEAlready a member? Sign in here.
Past Month
Leading Peers
-
$6.49 52.74%
-
$5.79 46.41%
-
$6.27 18.14%
Past Month
Lagging Peers
-
$10.24 -22.70%
-
$29.00 -19.23%
-
$11.64 -18.32%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!